CTY
City Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$18.09
−5.24%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.09x
- Price / sales
- 0.14x
- Price / cash flow
- 0.27x
Enterprise value
- Enterprise value
- $5.6B
- EV / sales
- 0.86x
- EV / EBITDA
- 1.55x
- EV / EBIT
- 1.97x
- Market cap
- $910.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2020